Kobayashi Pharmaceutical Overview
- Year Founded
-
1919
- Status
-
Public
- Employees
-
3,731
- Stock Symbol
-
4967
- Investments
-
16
- Share Price
-
$43.81
- (As of Thursday Closing)
Kobayashi Pharmaceutical General Information
Description
Kobayashi Pharmaceutical Co Ltd is engaged in the manufacture and sale of healthcare products, daily necessities, and body warmers. The company operates through two reportable segments: Domestic Business and International Business, which handle production and sales activities in Japan and overseas, respectively. The company's product portfolio includes disposable body warmers, cooling gel sheets, OTC pharmaceuticals, oral hygiene products, air fresheners, eyeglass wipes, and deodorizing/household sundries.
Contact Information
Website
www.kobayashi.co.jpCorporate Office
- KDX Kobayashi Doshomachi Building
- 4-4-10 Doshomachi, Chuo-ku
- Osaka, 541-0045
- Japan
Corporate Office
- KDX Kobayashi Doshomachi Building
- 4-4-10 Doshomachi, Chuo-ku
- Osaka, 541-0045
- Japan
Kobayashi Pharmaceutical Stock Performance
As of 12-Nov-2026, Kobayashi Pharmaceutical’s stock price is $43.81. Its current market cap is $3.26B with 74.3M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $43.81 | $43.67 | $32.71 - $46.71 | $3.26B | 74.3M | 266K | $0.39 |
Kobayashi Pharmaceutical Financials Summary
As of 30-Sep-2026, Kobayashi Pharmaceutical has a trailing 12-month revenue of $1.06B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 2,920,197 | 2,218,959 | 2,612,097 | 2,892,741 |
| Revenue | 1,062,346 | 1,107,400 | 1,093,442 | 1,234,465 |
| EBITDA | 81,394 | 143,660 | 237,926 | |
| Net Income | 29,171 | 24,427 | 66,472 | 144,744 |
| Total Assets | 1,590,728 | 1,760,112 | 1,689,916 | 1,896,568 |
| Total Debt | 4,218 | 4,334 | 5,387 | 6,999 |
Kobayashi Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kobayashi Pharmaceutical Comparisons
Industry
Financing
Details
Kobayashi Pharmaceutical Competitors (3)
One of Kobayashi Pharmaceutical’s 3 competitors is Breckenridge Pharmaceutical, a Corporate Backed or Acquired company based in NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Breckenridge Pharmaceutical | Corporate Backed or Acquired | NJ | ||||
| Taisho Pharmaceutical | Corporate Backed or Acquired | Tokyo, Japan | ||||
| Otsuka Holdings | Corporation | Tokyo, Japan |
Kobayashi Pharmaceutical Patents
Kobayashi Pharmaceutical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2026178445-A | Antiplasmin agents | Pending | 01-Sep-2026 | ||
| JP-2026178444-A | Emulsifying composition | Pending | 01-Sep-2026 | ||
| JP-2026174665-A | How to increase hair volume | Pending | 26-Aug-2026 | ||
| JP-2026174568-A | Denture adhesive | Pending | 19-Aug-2026 | ||
| JP-2026173008-A | Deodorizing composition | Pending | 28-Jul-2026 |
Kobayashi Pharmaceutical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Kobayashi Pharmaceutical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Kobayashi Pharmaceutical Investments & Acquisitions (16)
Kobayashi Pharmaceutical’s most recent deal was a Merger/Acquisition with Focus Consumer Healthcare for . The deal was made on 07-Oct-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Focus Consumer Healthcare | 07-Oct-2023 | Merger/Acquisition | Personal Products | ||
| Organtech | 31-Jul-2023 | Later Stage VC | Other Pharmaceuticals and Biotechnology | ||
| UNQ | 12-Jul-2021 | IPO | Specialty Retail | ||
| Alva-Amco | 12-Oct-2020 | Merger/Acquisition | Pharmaceuticals | ||
| Meitanhonpo Company | 14-May-2019 | Merger/Acquisition | Pharmaceuticals |
Kobayashi Pharmaceutical ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
28.27 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Household Products
Industry
of 104
Rank
Percentile
Personal Products
Subindustry
of 84
Rank
Percentile
Kobayashi Pharmaceutical Exits (2)
Kobayashi Pharmaceutical’s most recent exit was on 13-Oct-2005 from Concentric Medical. The exit was categorized as with 8 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Concentric Medical | 13-Oct-2005 | Completed |
|
||
| SurgRx | 16-Jan-2004 | Early Stage VC | Completed |
|
Kobayashi Pharmaceutical Affiliates
Subsidiaries (5)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Focus Consumer Healthcare | Chattanooga, TN | 2017 | |
| Xiaolin Pharmaceutical | Taizhou, China | 2003 | |
| Bluebird Development | Charleston, SC | 1996 | |
| Zim's Max Freeze | Dalton, GA | 1984 | |
| Alva-Amco | Niles, IL | 1904 |
Kobayashi Pharmaceutical FAQs
-
When was Kobayashi Pharmaceutical founded?
Kobayashi Pharmaceutical was founded in 1919.
-
Where is Kobayashi Pharmaceutical headquartered?
Kobayashi Pharmaceutical is headquartered in Osaka, Japan.
-
What is the size of Kobayashi Pharmaceutical?
Kobayashi Pharmaceutical has 3,731 total employees.
-
What industry is Kobayashi Pharmaceutical in?
Kobayashi Pharmaceutical’s primary industry is Pharmaceuticals.
-
Is Kobayashi Pharmaceutical a private or public company?
Kobayashi Pharmaceutical is a Public company.
-
What is Kobayashi Pharmaceutical’s stock symbol?
The ticker symbol for Kobayashi Pharmaceutical is 4967.
-
What is the current stock price of Kobayashi Pharmaceutical?
As of 12-Nov-2026 the stock price of Kobayashi Pharmaceutical is $43.81.
-
What is the current market cap of Kobayashi Pharmaceutical?
The current market capitalization of Kobayashi Pharmaceutical is $3.26B.
-
What is Kobayashi Pharmaceutical’s current revenue?
The trailing twelve month revenue for Kobayashi Pharmaceutical is $1.06B.
-
Who are Kobayashi Pharmaceutical’s competitors?
Breckenridge Pharmaceutical, Taisho Pharmaceutical, and Otsuka Holdings are competitors of Kobayashi Pharmaceutical.
-
What is Kobayashi Pharmaceutical’s annual earnings per share (EPS)?
Kobayashi Pharmaceutical’s EPS for 12 months was $0.39.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
